SAMD12 and hepatocellular carcinoma: A latest study showed that upregulation of SAMD12-AS1 in HCC cells reduces p53 stability through the NPM1-HDM2-p53 axis, thus affecting cell proliferation and apoptosis (Liu et al., 2019).